ArticleCells2022

Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis.

Jason Andrew Weesner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.